Have you or your loved ones been diagnosed with acyl-coa oxidase deficiency?

You may be eligible to participate in a acyl-coa oxidase deficiency clinical trial.

Have you or your loved ones been diagnosed with acyl-coa oxidase deficiency? You may be eligible to participate in a acyl-coa oxidase deficiency clinical trial.

What is a clinical trial? Is participating in a clinical trial right for you? Learn more

Recruiting for this study? Get access to patient recruitment tools.
Acyl-CoA Oxidase Deficiency Clinical Trial in Minneapolis MN
NCT02171104 | Phase 2 | Interventional

Have you or your loved ones been diagnosed with acyl-coa oxidase deficiency?

You may be eligible to participate in a acyl-coa oxidase deficiency clinical trial.

Have you or your loved ones been diagnosed with acyl-coa oxidase deficiency? You may be eligible to participate in a acyl-coa oxidase deficiency clinical trial.

Recruiting

Male & Female

Up to 55

Years old

This study is looking to recruit 100 Participants

This single-institution, phase II study is designed to test the ability to achieve donor hematopoietic engraftment while maintaining low rates of transplant-related mortality (TRM) using busulfan- and fludarabine-based conditioning regimens with busulfan therapeutic drug monitoring (TDM) for patients with various inherited metabolic disorders (IMD) and severe osteopetrosis (OP).

Where you'll go

Selected location

Masonic Cancer Center University of Minnesota

Masonic Cancer Center University of Minnesota Change

425 East River Parkway, Minneapolis, MN, USA 55455 Map | Learn more
Step 1 of 4: Email
Selected location

Masonic Cancer Center University of Minnesota

425 East River Parkway, Minneapolis, MN, USA 55455

Kim Nelson 612-273-2925
knelso62@fairview.org


The information you provide is confidential and is never sold or shared with outside vendors. By clicking the button, you agree to the PatientWing's Terms and Privacy Policy.